Structure

Quinapril

CAS
90243-99-5
Catalog Number
ACM90243995
Category
Other Products
Molecular Weight
492.99200
Molecular Formula
C25H33ClN2O6

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

IUPAC Name
3-Isoquinolinecarboxylic acid, 2-[2-[[1-(ethoxycarbonyl)-3-phenylpropy...
Exact Mass
492.20300
What is the PubChem CID of quinapril?

The PubChem CID of quinapril is 54892.

What is the molecular formula of quinapril?

The molecular formula of quinapril is C25H30N2O5.

What is the molecular weight of quinapril?

The molecular weight of quinapril is 438.5 g/mol.

What is the IUPAC name of quinapril?

The IUPAC name of quinapril is (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid.

What is the InChI of quinapril?

The InChI of quinapril is InChI=1S/C25H30N2O5/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30)/t17-,21-,22-/m0/s1.

What is the InChIKey of quinapril?

The InChIKey of quinapril is JSDRRTOADPPCHY-HSQYWUDLSA-N.

What is the canonical SMILES of quinapril?

The canonical SMILES of quinapril is CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O.

What is the common synonym for quinapril?

The common synonym for quinapril is Quinaprilum.

What is the pharmacological class of quinapril?

The pharmacological class of quinapril is an angiotensin-converting enzyme inhibitor (ACE inhibitor).

When was quinapril granted FDA approval?

Quinapril was granted FDA approval on November 19, 1991.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Inquiry Basket
qrcodex
Download
Verification code
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.